135 related articles for article (PubMed ID: 33370338)
21. Autophagy in cancer resistance to paclitaxel: Development of combination strategies.
Škubník J; Svobodová Pavlíčková V; Ruml T; Rimpelová S
Biomed Pharmacother; 2023 May; 161():114458. PubMed ID: 36889112
[TBL] [Abstract][Full Text] [Related]
22. Novel Approaches in Ovarian Cancer Research against Heterogeneity, Late Diagnosis, Drug Resistance, and Transcoelomic Metastases.
Erol A; Niemira M; Krętowski AJ
Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146417
[TBL] [Abstract][Full Text] [Related]
23. The role of the MAD2-TLR4-MyD88 axis in paclitaxel resistance in ovarian cancer.
Bates M; Spillane CD; Gallagher MF; McCann A; Martin C; Blackshields G; Keegan H; Gubbins L; Brooks R; Brooks D; Selemidis S; O'Toole S; O'Leary JJ
PLoS One; 2020; 15(12):e0243715. PubMed ID: 33370338
[TBL] [Abstract][Full Text] [Related]
24. The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer.
d'Adhemar CJ; Spillane CD; Gallagher MF; Bates M; Costello KM; Barry-O'Crowley J; Haley K; Kernan N; Murphy C; Smyth PC; O'Byrne K; Pennington S; Cooke AA; Ffrench B; Martin CM; O'Donnell D; Hennessy B; Stordal B; Finn S; McCann A; Gleeson N; D'Arcy T; Flood B; O'Neill LA; Sheils O; O'Toole S; O'Leary JJ
PLoS One; 2014; 9(6):e100816. PubMed ID: 24977712
[TBL] [Abstract][Full Text] [Related]
25. Role of TLR4 for paclitaxel chemotherapy in human epithelial ovarian cancer cells.
Wang AC; Su QB; Wu FX; Zhang XL; Liu PS
Eur J Clin Invest; 2009 Feb; 39(2):157-64. PubMed ID: 19200169
[TBL] [Abstract][Full Text] [Related]
26. Galectin-3 induces ovarian cancer cell survival and chemoresistance via TLR4 signaling activation.
Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
Tumour Biol; 2016 Sep; 37(9):11883-11891. PubMed ID: 27059733
[TBL] [Abstract][Full Text] [Related]
27. Effect of Mad2 on paclitaxel-induced cell death in ovarian cancer cells.
Hao X; Zhou Z; Ye S; Zhou T; Lu Y; Ma D; Wang S
J Huazhong Univ Sci Technolog Med Sci; 2010 Oct; 30(5):620-5. PubMed ID: 21063845
[TBL] [Abstract][Full Text] [Related]
28. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
[TBL] [Abstract][Full Text] [Related]
29. Too MAD or not MAD enough: The duplicitous role of the spindle assembly checkpoint protein MAD2 in cancer.
Bates M; Furlong F; Gallagher MF; Spillane CD; McCann A; O'Toole S; O'Leary JJ
Cancer Lett; 2020 Jan; 469():11-21. PubMed ID: 31593803
[TBL] [Abstract][Full Text] [Related]
30. The prognostic values of matrix metalloproteinases in ovarian cancer.
Zeng L; Qian J; Zhu F; Wu F; Zhao H; Zhu H
J Int Med Res; 2020 Jan; 48(1):300060519825983. PubMed ID: 31099295
[TBL] [Abstract][Full Text] [Related]
31. Senolytics and senostatics as adjuvant tumour therapy.
Short S; Fielder E; Miwa S; von Zglinicki T
EBioMedicine; 2019 Mar; 41():683-692. PubMed ID: 30737084
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.
Yoneda M; Imamura R; Nitta H; Taniguchi K; Saito F; Kikuchi K; Ogi H; Tanaka T; Katabuchi H; Nakayama H; Imamura T
Oncol Lett; 2019 Jan; 17(1):913-920. PubMed ID: 30655847
[TBL] [Abstract][Full Text] [Related]
33. Ectodomain Shedding of RAGE and TLR4 as a Negative Feedback Regulation in High-Mobility Group Box 1-Activated Aortic Endothelial Cells.
Yang WS; Kim JJ; Lee MJ; Lee EK; Park SK
Cell Physiol Biochem; 2018; 51(4):1632-1644. PubMed ID: 30497069
[TBL] [Abstract][Full Text] [Related]
34. HER2 decreases drug sensitivity of ovarian cancer cells via inducing stem cell-like property in an NFκB-dependent way.
Wang W; Gao Y; Hai J; Yang J; Duan S
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30314995
[TBL] [Abstract][Full Text] [Related]
35. Complement system's role in cancer and its therapeutic potential in ovarian cancer.
Bareke H; Akbuga J
Scand J Immunol; 2018 Jul; 88(1):e12672. PubMed ID: 29734524
[TBL] [Abstract][Full Text] [Related]
36. Role of TLR4 as a prognostic factor for survival in various cancers: a meta-analysis.
Hao B; Chen Z; Bi B; Yu M; Yao S; Feng Y; Yu Y; Pan L; Di D; Luo G; Zhang X
Oncotarget; 2018 Feb; 9(16):13088-13099. PubMed ID: 29560134
[TBL] [Abstract][Full Text] [Related]
37. MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Block MS; Vierkant RA; Rambau PF; Winham SJ; Wagner P; Traficante N; Tołoczko A; Tiezzi DG; Taran FA; Sinn P; Sieh W; Sharma R; Rothstein JH; Ramón Y Cajal T; Paz-Ares L; Oszurek O; Orsulic S; Ness RB; Nelson G; Modugno F; Menkiszak J; McGuire V; McCauley BM; Mack M; Lubiński J; Longacre TA; Li Z; Lester J; Kennedy CJ; Kalli KR; Jung AY; Johnatty SE; Jimenez-Linan M; Jensen A; Intermaggio MP; Hung J; Herpel E; Hernandez BY; Hartkopf AD; Harnett PR; Ghatage P; García-Bueno JM; Gao B; Fereday S; Eilber U; Edwards RP; de Sousa CB; de Andrade JM; Chudecka-Głaz A; Chenevix-Trench G; Cazorla A; Brucker SY; ; Alsop J; Whittemore AS; Steed H; Staebler A; Moysich KB; Menon U; Koziak JM; Kommoss S; Kjaer SK; Kelemen LE; Karlan BY; Huntsman DG; Høgdall E; Gronwald J; Goodman MT; Gilks B; García MJ; Fasching PA; de Fazio A; Deen S; Chang-Claude J; Candido Dos Reis FJ; Campbell IG; Brenton JD; Bowtell DD; Benítez J; Pharoah PDP; Köbel M; Ramus SJ; Goode EL
Mayo Clin Proc; 2018 Mar; 93(3):307-320. PubMed ID: 29502561
[TBL] [Abstract][Full Text] [Related]
38. BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma.
Byrne T; Nelson L; Beirne JP; Sharpe D; Quinn JE; McCluggage WG; Robson T; Furlong F
Int J Gynecol Cancer; 2018 Mar; 28(3):472-478. PubMed ID: 29465507
[TBL] [Abstract][Full Text] [Related]
39. Cancer statistics, 2018.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2018 Jan; 68(1):7-30. PubMed ID: 29313949
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
